Tevano Systems Holdings Inc. (TEVNF)
USD 0.0
(-99.76%)
USD 0.0
(-99.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - CAD | 100.0% |
| 2022 | -4.2 Million CAD | 20.2% |
| 2021 | -5.61 Million CAD | -17369.52% |
| 2020 | -1742.34 CAD | 49.93% |
| 2019 | -64.19 Thousand CAD | 76.58% |
| 2018 | -274.05 Thousand CAD | 56.85% |
| 2017 | -635.07 Thousand CAD | 45.23% |
| 2016 | -1.15 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q2 | -181.79 Thousand CAD | -340.6% |
| 2023 Q1 | -41.26 Thousand CAD | 90.68% |
| 2023 FY | - CAD | 100.0% |
| 2023 Q3 | -457.2 Thousand CAD | -151.5% |
| 2023 Q4 | - CAD | 100.0% |
| 2022 Q3 | -701.66 Thousand CAD | 74.54% |
| 2022 Q1 | -656.3 Thousand CAD | 78.92% |
| 2022 FY | - CAD | 20.2% |
| 2022 Q4 | -442.7 Thousand CAD | 36.91% |
| 2022 Q2 | -2.75 Million CAD | -319.85% |
| 2021 Q1 | -292.5 Thousand CAD | 0.0% |
| 2021 FY | - CAD | -17369.52% |
| 2021 Q3 | -1.48 Million CAD | 0.0% |
| 2021 Q4 | -3.11 Million CAD | -109.69% |
| 2020 FY | - CAD | 49.93% |
| 2020 Q3 | -244.1 Thousand CAD | 0.0% |
| 2019 FY | - CAD | 76.58% |
| 2018 FY | - CAD | 56.85% |
| 2017 FY | - CAD | 45.23% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 100.0% |
| Ansell Limited | 209.86 Million USD | 100.0% |
| Ansell Limited | 206.3 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 42.83 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -1.62 Million USD | 100.0% |
| Psykey, Inc. | -1.29 Million USD | 100.0% |
| ConvaTec Group Plc | 455.5 Million USD | 100.0% |
| ConvaTec Group Plc | 455.5 Million USD | 100.0% |
| Encision Inc. | -544.19 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -7.67 Million USD | 100.0% |
| LifePoint, Inc. | -14.2 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -215.23 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -186.13 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.0% |
| SheerVision, Inc. | -110.53 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.5 Million USD | 100.0% |
| Vasamed, Inc. | -4.57 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.17 Million USD | 100.0% |